Keyphrases
Abdomen
9%
Acid Concentration
72%
Body Mass Index
9%
Bone Mineral Density
72%
Cardiovascular Mortality
9%
Chronic Kidney Disease
100%
Circulating Bile Acid
100%
Circulating Markers
9%
Clinical Trial Participant
9%
Cohort Analysis
9%
Complete Data
9%
Computed Tomography
9%
Coronary Artery
100%
Coronary Artery Calcification
72%
Deoxycholic Acid
100%
Dietary Intake
9%
Estimated Glomerular Filtration Rate
18%
Fibroblast Growth Factor 23 (FGF23)
9%
Illness
9%
Intact Parathyroid Hormone (iPTH)
9%
Kidney Disease Progression
18%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
9%
Mineral Metabolism
9%
Mineral Transformation
9%
Moderate to Severe
18%
Negatively Associated
9%
Non-fasting
9%
Osteogenic Differentiation
9%
Phantom
9%
Phosphate Binder
9%
Phosphorus
9%
Randomized Controlled Study
9%
Serum Calcium
9%
Serum Samples
18%
Trial Participants
9%
Vascular Calcification
100%
Vascular Mineralization
9%
Vitamin D
9%
Volume Score
45%
Pharmacology, Toxicology and Pharmaceutical Science
Bile Acid
100%
Blood Vessel Calcification
100%
Cardiovascular Disease
9%
Chronic Kidney Failure
100%
Clinical Trial
9%
Coronary Artery Calcification
72%
Deoxycholic Acid
100%
Diseases
9%
Fibroblast Growth Factor 23
9%
Parathyroid Hormone
9%
Phosphate Binding Agent
9%
Vitamin D
9%
Biochemistry, Genetics and Molecular Biology
Animal Models
9%
Bile Acid
100%
Body Mass
9%
Bone Density
72%
Calcium Blood Level
9%
Clinical Trial
9%
Computer Assisted Tomography
9%
Deoxycholic Acid
100%
Fibroblast Growth Factor 23
9%
Glomerulus Filtration
18%
Mass Spectrometry
9%
Metabolite
100%
Mineral Metabolism
9%
Mineralization
9%
Parathyroid Hormone
9%
Vitamin D
9%
Food Science
Dietary Intake
100%
Fibroblast Growth Factor
100%
Vitamin D
100%
Neuroscience
Bile Acid
100%
Body Mass Index
9%
Cohort Analysis
9%
Deoxycholic Acid
100%
Fibroblast Growth Factor 23
9%
Mass Spectrometry
9%
Metabolic Pathway
9%
Parathyroid Hormone
9%
Phosphate Binder
9%
Vitamin D
9%